Home/Filings/4/0001209191-22-049217
4//SEC Filing

Swanson Ronald V. 4

Accession 0001209191-22-049217

CIK 0001863127other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 5:51 PM ET

Size

11.8 KB

Accession

0001209191-22-049217

Insider Transaction Report

Form 4
Period: 2022-09-06
Swanson Ronald V.
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2022-03-15$8.53/sh+3,125$26,642273,254 total
  • Award

    Stock Option (Right to Buy)

    2022-09-06+105,000105,000 total
    Exercise: $7.14Exp: 2032-09-05Common Stock (105,000 underlying)
Footnotes (2)
  • [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
  • [F2]1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001880662

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:51 PM ET
Size
11.8 KB